RedHill plans to commercialize its leading drug candidates in the U.S., either through its own efforts or in conjunction with partners. Outside of the U.S. RedHill seeks commercialization partners for its products.
RedHill seeks to collaborate with pharmaceutical companies with a proven R&D track record and strong commercial capabilities.
RedHill also seeks to in-license or acquire FDA approved products, marketed in the U.S., in the therapeutic areas of GI, inflammation and oncology.
If you are interested in exploring partnering, licensing and business development opportunities with RedHill, please contact:
Mr. Adi Frish, Senior VP Business Development & Licensing
Tel.: +972 (0)3 541 3138
Upcoming Events & Presentations
For upcoming conferences and meetings, please visit the Investors section